Docebo (NASDAQ:DCBO) is pursuing new growth initiatives across government, skills management, healthcare and artificial intelligence as it continues its shift toward larger enterprise customers, CFO Brandon Farber said at the Oppenheimer Technology Conference.
Farber described Docebo as a learning
Docebo (NASDAQ:DCBO) said its underlying growth accelerated for a second consecutive quarter as the company gains traction with larger enterprise customers, expands its artificial intelligence product portfolio and begins integrating its recent skills-intelligence acquisition.
Speaking at Canaccord
Docebo (NASDAQ:DCBO) executives said the company’s annual recurring revenue growth re-accelerated for a second consecutive quarter in the second quarter of 2026, supported by enterprise execution, partner activity, international performance and expansion business. Management also discussed planned i
Docebo (NASDAQ:DCBO) is seeing improved enterprise demand after addressing product and go-to-market gaps that weighed on its business in 2025, Brandon Farber of Docebo said during a Needham fireside chat hosted by analyst Ryan MacDonald.
Farber described Docebo as a learning management system provi
Docebo (NASDAQ:DCBO) used its Q1 2026 earnings call primarily to discuss demand trends and customer interest following its recent Inspire user conference, with executives emphasizing traction in enterprise, expansion opportunities tied to new products, and momentum in government markets. Management
Artificial Intelligence (AI) stands at the precipice of revolutionizing healthcare, promising breakthroughs in diagnostics, personalized treatment, and operational efficiency. However, the path to widespread, ethical, and effective AI adoption in medical settings is fraught with significant challenges. As of December 12, 2025, the immediate significance of these hurdles—encompassing the critical need for trust, comprehensive clinician [...]
